Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam-Reference-Cited by-同舟云学术

Comparison of Etest to Broth Microdilution for Testing of Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam

Published:2017-01 Issue:1 Volume:55 Page:334-335
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Flynt Lauren K.¹,Veve Michael P.¹²,Samuel Linoj P.¹,Tibbetts Robert J.¹

Affiliation:

1. Henry Ford Hospital, Detroit, Michigan, USA

2. Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01920-16

Reference11 articles.

1. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention Atlanta GA. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed 2 September 2016.

2. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

3. New β-Lactamase Inhibitors in the Clinic

4. Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape

5. Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa;Enfermedades infecciosas y microbiologia clinica (English ed.);2023-12

2. Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa;Enfermedades Infecciosas y Microbiología Clínica;2022-12

3. Evaluation of in vitro activity of ceftolozane-tazobactam in combination with other classes of antibacterial agents against Enterobacterales and Pseudomonas aeruginosa—the EM200 study;New Microbes and New Infections;2021-05

4. Verification Is an Integral Part of Antimicrobial Susceptibility Test Quality Assurance;Journal of Clinical Microbiology;2020-03-25

5. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia;Pathology;2018-12